B7-H1, A Novel Immunoregulatory Molecule

Patent No. EP1234031 (titled "B7-H1, A Novel Immunoregulatory Molecule") was filed by Mayo Foundation FOR Medical Education And Research on Nov 30, 2000. The application was issued on Nov 24, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERCK SHARP & DOHMEDec 15, 2017BOHLES
NEUEFEINDDec 15, 2017-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1234031

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Application Number
EP00983821A
Filing Date
Nov 30, 2000
Status
Patent Maintained As Amended
Oct 22, 2021
Publication Date
Nov 24, 2021